共 50 条
- [31] Comparing docetaxel plus cisplatin versus fluorouracil plus cisplatin in esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapyJAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2017, 47 (08) : 683 - 689Xi, MianZhang, PengZhang, LiYang, Ya-DiLiu, Shi-LiangLi, YongFu, Jian-HuaLiu, Meng-Zhong
- [32] Fluoropyrimidines plus Cisplatin versus Gemcitabine/Gemcitabine plus Cisplatin in Locally Advanced and Metastatic Biliary Tract Carcinoma - A Retrospective StudyJOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2012, 21 (03) : 277 - 284Croitoru, AdinaGramaticu, JuliaDinu, IoanaGheorghe, LianaAlexandrescu, SorinBuica, FlorinaLuca, IoanaBecheanu, GabrielHerlea, VladSimionov, IuliaHrehoret, DoinaLupescu, IoanaPopescu, IrinelDiculescu, Mircea
- [33] A RANDOMIZED PHASE II TRIAL OF TWO DIFFERENT FOUR DRUG COMBINATIONS IN ADVANCED PANCREATIC ADENOCARCINOMA: CISPLATIN, CAPECITABINE, GEMCITABINE PLUS EITHER EPIRUBICIN OR DOCETAXELANNALS OF ONCOLOGY, 2009, 20Cereda, StefanoReni, MicheleRognone, AlessiaGhidini, MicheleRezzonico, SaraPassoni, PaoloMazza, ElenaBelli, CarmenZerbi, AlessandroVilla, Eugenio
- [34] Induction chemotherapy regimen of docetaxel plus cisplatin vs docetaxel, cisplatin plus fluorouracil followed by concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: Preliminary results of a phase III multicenter randomized controlled trialANNALS OF ONCOLOGY, 2022, 33 : S1521 - S1521He, S.Wang, Y.Wang, C.Peng, Z.Chen, Y.
- [35] Randomized phase II study comparing docetaxel plus cisplatin, docetaxel plus carboplatin, and paclitaxel plus carboplatin in patients with advanced or recurrent endometrial carcinoma: a Japanese Gynecologic Oncology Group study (JGOG2041)ANNALS OF ONCOLOGY, 2011, 22 (03) : 636 - 642Nomura, H.Aoki, D.Takahashi, F.Katsumata, N.Watanabe, Y.Konishi, I.Jobo, T.Hatae, M.Hiura, M.Yaegashi, N.
- [36] Randomized phase II study comparing docetaxel plus cisplatin, docetaxel plus carboplatin, and paclitaxel plus carboplatin in patients with advanced or recurrent endometrial carcinoma: Japanese Gynecologic Oncology Group trial (JGOG2041)JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)Nomura, H.Aoki, D.Takahashi, F.Katsumata, N.Watanabe, Y.Konishi, I.Jobo, T.Hatae, M.Hiura, M.Yaegashi, N.
- [37] A randomized phase II trial of docetaxel plus S-1 versus docetaxel plus cisplatin in advanced gastric cancer as a first-line treatmentJOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)Jeung, H.Im, C.Rha, S.Ahn, J.Shin, S.Noh, S.Roh, J.Chung, H.
- [38] Randomized Phase III Study of Nedaplatin plus Docetaxel versus Cisplatin plus Docetaxel for Advanced Squamous Cell Lung Cancer (WJOG5208L)JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S173 - S173Seto, TakashiShukuya, TakehitoYamanaka, TakeharuHirashima, TomonoriKato, TerufumiHorio, YoshitsuguAtagi, ShinjiInoue, TakakoOhsaki, YoshinobuMaeda, TadashiNishi, KoichiSawa, ToshiyukiOkada, MorihitoFujimoto, DaichiHarada, TaishiNakagawa, KazuhikoNakanishi, YoichiYamamoto, Nobuyuki
- [39] Nedaplatin Plus Docetaxel Versus Cisplatin Plus Docetaxel as First-Line Chemotherapy for Advanced Squamous Cell Carcinoma of the Lung - A Multicenter, Open-label, Randomized, Phase III TrialJOURNAL OF THORACIC ONCOLOGY, 2018, 13 (11) : 1743 - 1749Lu, ShunChen, ZhiweiHu, ChengpingZhang, JianChen, YuanSong, YongZhao, QiongFan, YunWu, GangMa, ZhiyongFang, JianYu, QitaoLiu, Zhe
- [40] Gemcitabine combined with docetaxel for the treatment of unresectable pancreatic carcinomaCANCER INVESTIGATION, 2004, 22 (04) : 505 - 514Jacobs, ADOtero, HPicozzi, VJAboulafia, DM